SMM Global – Stock Market Manager Stock Market Manager simplifies distribution and disclosure of press releases, research and corporate news to financial terminals, print, broadcast and trade media, wire services, news agencies, databases, portals and websites.
Coeptis Therapeutics COEP
Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP), together with its subsidiaries (including Coeptis Therapeutics, Inc. and Coeptis Pharmaceuticals, Inc., (collectively “Coeptis”), is a biopharmaceutical company developing innovative cell therapy platforms for patients with cancer. Coeptis was founded in 2017 and is headquartered in Wexford, PA.
Stock Market Manager Weekly Update: March 6th, 2024
Weekly Update: March 6th, 2024 Black Swan Connection Newsletter Signup Breaking News The magnificent 7 tumble and the talk is that the upcoming inflation report could spark the stock market’s next …
Stock Market Manager Weekly Update: February 14th, 2024
Weekly Update: February 14th, 2024 Black Swan Connection Newsletter Signup Breaking News Not much to get excited about from the markets even though we have a decent bounce today. Shows how …
Stock Market Manager Weekly Update: December 28th, 2023
Weekly Update: December 28th, 2023 Black Swan Connection Newsletter Signup Breaking News It’s a Christmas Miracle!! Stocks pop as Nasdaq closes in on best year since 2003. Seems in spite of 2 …
Description
Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP), together with its subsidiaries (including Coeptis Therapeutics, Inc. and Coeptis Pharmaceuticals, Inc., (collectively “Coeptis”), is a biopharmaceutical company developing innovative cell therapy platforms for patients with cancer. Coeptis was founded in 2017 and is headquartered in Wexford, PA.
Contact Information
105 Bradford Rd
Suite 420
Wexford, PA 15090
Financial Reporting/Disclosure
Reporting Status : U.S. Reporting: SEC Reporting
Latest Report : 12/31/22 10-Q
CIK : 0001759186
Fiscal Year End : 12/31
NASDAQ : COEP
Profile Data
SIC – Industry Classification : Not Available
Incorporated In : NV, USA
Year of Inc. : Not Available
Employees : Not Available
Company Officers/Contacts
Dave Mehalick ┃ Chairman, President and Chief Exec. Officer
Christine Sheehy ┃ CFO
Dan Yerace┃ Director and VP of Operations
Dr. Everin Alici Ph.D., MD ┃ Head of Gene Cell Therapy Group
Dr. Hans-Gustaf Ljunggren Ph.D., MD ┃